Literature DB >> 15561643

Obesity: epidemiology and clinical aspects.

Xavier Formiguera1, Ana Cantón.   

Abstract

At the beginning of the 21st Century, obesity has become the leading metabolic disease in the World. So much so, that the World Health Organisation refers to obesity as the global epidemic. In fact, obesity is a common disease affecting not only affluent societies but also developing countries. Currently 300 million people can be considered as obese and, due to the rising trend in obesity prevalence, this figure could double by year 2025 if no action is taken against this threat. In terms of health impairment, the importance of obesity lies in the fact that, besides being a disease in itself, it is a risk for many other diseases, mainly from the metabolic and cardiovascular area. Among these, type 2 diabetes, dyslipemia, hyperuricemia, arterial hypertension and cardiovascular disease are the most frequent. Also, respiratory diseases such as obesity hypoventilation syndrome and obstructive sleep apnoea syndrome are strongly associated with obesity.

Entities:  

Mesh:

Year:  2004        PMID: 15561643     DOI: 10.1016/j.bpg.2004.06.030

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  72 in total

1.  Inhibitory effects of compounds isolated from the dried branches and leaves of murta (Myrceugenia euosma) on lipid accumulation in 3T3-L1 cells.

Authors:  Naoki Oikawa; Yasuhito Nobushi; Taira Wada; Kumiko Sonoda; Yuzo Okazaki; Shigetoshi Tsutsumi; Yong Kun Park; Masahiko Kurokawa; Shigeki Shimba; Ken Yasukawa
Journal:  J Nat Med       Date:  2016-02-15       Impact factor: 2.343

Review 2.  [Comorbidities and complications of adiposis].

Authors:  C Dieterle; R Landgraf
Journal:  Internist (Berl)       Date:  2006-02       Impact factor: 0.743

3.  Hepatic evisceration after cholecystectomy in a super obese patient.

Authors:  José Ignacio Rodríguez-Hermosa; Bartomeu Ruiz-Feliú; Josep Roig-García; Jordi Gironès-Vilà; Pere Planellas-Giné; Pedro Ortuño-Muro; Antoni Codina-Cazador
Journal:  Obes Surg       Date:  2008-01-05       Impact factor: 4.129

4.  Metabolic syndrome and sleep apnea.

Authors:  I Kostoglou-Athanassiou; P Athanassiou
Journal:  Hippokratia       Date:  2008-04       Impact factor: 0.471

5.  The spatial repositioning of adipogenesis genes is correlated with their expression status in a porcine mesenchymal stem cell adipogenesis model system.

Authors:  Izabela Szczerbal; Helen A Foster; Joanna M Bridger
Journal:  Chromosoma       Date:  2009-07-08       Impact factor: 4.316

6.  Hepatic evisceration after cholecystectomy in a superobese patient.

Authors:  José Ignacio Rodríguez-Hermosa; Bartomeu Ruiz-Feliú; Josep Roig-García; Jordi Gironès-Vilà; Pere Planellas-Giné; Pedro Ortuño-Muro; Antoni Codina-Cazador
Journal:  Obes Surg       Date:  2008-05-28       Impact factor: 4.129

7.  The risk of Barrett's esophagus associated with abdominal obesity in males and females.

Authors:  Bradley J Kendall; Graeme A Macdonald; Nicholas K Hayward; Johannes B Prins; Suzanne O'Brien; David C Whiteman
Journal:  Int J Cancer       Date:  2012-10-30       Impact factor: 7.396

8.  Influence of oryzanol and ferulic Acid on the lipid metabolism and antioxidative status in high fat-fed mice.

Authors:  Myoung Jin Son; Catherine W Rico; Seok Hyun Nam; Mi Young Kang
Journal:  J Clin Biochem Nutr       Date:  2010-02-27       Impact factor: 3.114

9.  Anti-obesity effect of an isoflavone fatty acid ester on obese mice induced by high fat diet and its potential mechanism.

Authors:  Yao Yao; Xiao-Bo Li; Wei Zhao; Yan-Yan Zeng; Hong Shen; Hua Xiang; Hong Xiao
Journal:  Lipids Health Dis       Date:  2010-05-19       Impact factor: 3.876

10.  Grape seed extract (Vitis vinifera) partially reverses high fat diet-induced obesity in C57BL/6J mice.

Authors:  Su-Hui Park; Tae-Sun Park; Youn-Soo Cha
Journal:  Nutr Res Pract       Date:  2008-12-31       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.